Hostname: page-component-586b7cd67f-t8hqh Total loading time: 0 Render date: 2024-12-01T00:10:49.406Z Has data issue: false hasContentIssue false
  • English
  • Français

Achromobacter xylosoxidans Bacteremia

Published online by Cambridge University Press:  21 June 2016

Kathleen A. McGann ,
Mary Provencher ,
Cindy Hoegg  and
George H. Talbot
Kathleen A. McGann
Affiliation:
Infectious Diseases Section, the Childrens' Hospital of Philadelphia, Philadelphia, Pennsylvania
Mary Provencher
Affiliation:
Infectious Diseases Section, the University of Pennsylvania School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
Cindy Hoegg
Affiliation:
Infectious Diseases Section, the University of Pennsylvania School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
George H. Talbot*
Affiliation:
Infectious Diseases Section, the University of Pennsylvania School of Medicine and the Infection Control Section, Hospital of the University of Pennsylvania, Philadelphia, Pennsylvania
*
Infection Control, One Gibson, Hospital of the University of Pennsylvania, 3400 Spruce Street, Philadelphia, PA 19104
Get access Rights & Permissions [Opens in a new window]

Extract

Achromobacter xylosoxidans is a nonfermenting, oxidase-positive, gram-negative rod that prefers aqueous environmental reservoirs. A variety of such sources have been implicated in epidemic and sporadic A xylosoxidans infections, including the deionized water of a hemodialysis system, a swimming pool chlorhexidine solutions, intravascular pressure transducers and distilled water. Nuclear medicine tracer material prepared at our institution was implicated in a 1978 outbreak that involved four hospitals. Fourteen patients developed proven or suspected A xylosoxidans bacteremia following intravenous injection with this tracer for lung, liver and bone scans. Contaminated non-bacteriostatic saline used as a diluent for the radioactive material was the likely source.

A xylosoxidans has been isolated from many different body sites, including the bloodstream, urinary tract, central nervous system, peritoneum, respiratory tract, biliary tree; bowel, eyes, ears, pharynx and surgical wounds. Many infected individuals have had compromised host defenses of varying types. Serious infections with this organism may be fatal, perhaps, in part, because of its resistance to multiple antibiotics.

Type
Topics in Clinical Microbiology
Information
Infection Control & Hospital Epidemiology , Volume 11 , Issue 10 , October 1990 , pp. 539 - 541
Copyright
Copyright © The Society for Healthcare Epidemiology of America 1990 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

References

1. Igra-Siegman, Y, Chmel, H, Cobbs, C. Clinical and laboratory characteristics of Achromobacter xylosoxidans infection. J Clin Microbiol. 1980;11:141–145.CrossRefGoogle ScholarPubMed
2. Schoch, PE, Cunha, BA. Nosocomial Achromobacter xylosoxidans infections. Infect Control Hosp Epidemiol. 1988;9:84–87.CrossRefGoogle ScholarPubMed
3. Mandell, W, Garvey, G, Neu, H. Achromobacter xylosoxidans bacteremia. Rev Infect Dis. 1987;9:1001–1005.CrossRefGoogle ScholarPubMed
4. Reverdy, ME, Freney, J, Fleurette, J, et al. Nosocomial colonization and infection with Achromobacter xylosoxidans J Clin Microbiol. 1984;19:140–143.CrossRefGoogle ScholarPubMed
5. Holmes, B, Snell, J, LaPage, S. Strains of Achromobacter xylosoxidans from clinical material. J Clin Path. 1977;30:595–601.CrossRefGoogle ScholarPubMed
6. Shigeta, S, Yasunaga, Y, Honzumi, K, Okamura, H, Kumata, R, Endo, S. Cerebral ventriculitis associated with Achromobacter xylosoxidans . J Clin Path. 1978;31:156–161.CrossRefGoogle ScholarPubMed
7. Gahm-Hansen, B, Alstrup, P, Dessau, R, et al. Outbreak of infection with Achromobacter xylosoxidans from contaminated intravascular pressure transducers. J Hosp Infect. 1988;12:1–6.CrossRefGoogle Scholar
8. McGuckin, MB, Thorpe, RJ, Koch, KM, Alani, A, Staum, M, Abrutyn, E. An outbreak of Achromobacter xylosoxidans related to diagnostic tracer procedures. Am J Epidemiol. 1982;115:785–793.CrossRefGoogle ScholarPubMed
9. Chandrasekar, PH, Arathoon, E, Levine, DP. Infection due to Achromobacter xylosoxidans. Case report and review of the literature. Infection. 1986;14:279–282.CrossRefGoogle ScholarPubMed
10. Pien, FD, Higa, HY. Achromobacter xylosoxidans isolates in Hawaii. J Clin Microbiol. 1978;7:239–241.CrossRefGoogle ScholarPubMed
11. Lennette, EH, Balows, A, Hausler, WJ, Shadomy, HJ. Manual of Clinical Microbiology. 4th ed. Washington, DC: American Society for Microbiology; 1985.Google Scholar
12. Manzella, JP. Achromobacter xylosoxidans bacteremia. Dig Dis Sci. 1987;32:781–782.CrossRefGoogle ScholarPubMed
13. Arroyo, JC, Jordan, W, Lema, MW, Brown, A. Diversity of plasmids in Achromobacter xylosoxidans isolates responsible for a seemingly common-source outbreak. J Clin Microbiol. 1987;25:1952–1955.CrossRefGoogle Scholar
14. Yabuuchi, E, Yano, I, Goto, S, Tanimura, E, Ito, T, Ohyama, A. Description of Achromobacter xylosoxidans Yabuuchi and Ohyama (1971). Int J Syst Bacteriol. 1974;24:470–477.CrossRefGoogle Scholar
15. Glupczynski, Y, Hansen, W, Freney, J, Yourassowsky, E. In vitro susceptibility of Alcaligenes denitrificans subsp. xylosoxidans to 24 antimicrobial agents. Antimicrob Agents Chemother. 1988;32:276–278.CrossRefGoogle ScholarPubMed